NO832905L - Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse - Google Patents

Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse

Info

Publication number
NO832905L
NO832905L NO832905A NO832905A NO832905L NO 832905 L NO832905 L NO 832905L NO 832905 A NO832905 A NO 832905A NO 832905 A NO832905 A NO 832905A NO 832905 L NO832905 L NO 832905L
Authority
NO
Norway
Prior art keywords
cea
fraction
column
proteins
buffer
Prior art date
Application number
NO832905A
Other languages
English (en)
Norwegian (no)
Inventor
Rolf Lammerz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO832905L publication Critical patent/NO832905L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO832905A 1982-08-14 1983-08-12 Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse NO832905L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Publications (1)

Publication Number Publication Date
NO832905L true NO832905L (no) 1984-02-15

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
NO832905A NO832905L (no) 1982-08-14 1983-08-12 Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse

Country Status (13)

Country Link
EP (1) EP0102008A3 (index.php)
JP (1) JPS5950360A (index.php)
AU (1) AU1796083A (index.php)
DD (1) DD211714A5 (index.php)
DE (1) DE3230299A1 (index.php)
DK (1) DK368783A (index.php)
ES (1) ES8404187A1 (index.php)
FI (1) FI832899A7 (index.php)
GR (1) GR78692B (index.php)
IL (1) IL69476A0 (index.php)
NO (1) NO832905L (index.php)
PT (1) PT77199B (index.php)
ZA (1) ZA835947B (index.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
GR78692B (index.php) 1984-09-27
ES524909A0 (es) 1984-05-01
DD211714A5 (de) 1984-07-25
ZA835947B (en) 1984-04-25
DK368783D0 (da) 1983-08-12
ES8404187A1 (es) 1984-05-01
FI832899L (fi) 1984-02-15
AU1796083A (en) 1985-02-21
JPS5950360A (ja) 1984-03-23
EP0102008A3 (de) 1987-01-28
IL69476A0 (en) 1983-11-30
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DE3230299A1 (de) 1984-02-16
PT77199B (de) 1986-03-27
DK368783A (da) 1984-02-15
FI832899A0 (fi) 1983-08-11
FI832899A7 (fi) 1984-02-15

Similar Documents

Publication Publication Date Title
Ishizaka et al. Antigenic Structure of γE-Gobulin and Reaginic Antibody
US4383985A (en) Breast cancer antigens
GRUNERT et al. Two CEA and three NCA species, although distinguishable by monoclonal antibodies, have nearly identical peptide patterns
CA1154438A (en) Protein pp in15 xx, a process for its preparation and its use
JPH0244030B2 (index.php)
NZ187548A (en) Glycoprotein and antiserum
Stenner et al. Monoclonal antibodies to native noncollagenous bone-specific proteins.
US4500451A (en) New protein PP13 extracted from human placental tissues and use thereof
US4683135A (en) DSCG binding protein and process for preparing same
Lospalluto et al. Chromatographic properties of gamma globulin: behavior of serum gamma macroglobulins
Brandtzaeg HUMAN SECRETORY IMMUNOGLOBULINS: 4. Quantitation of Free Secretory Piece
Matsuoka et al. Isolation and Characterization of Free λ-Chain of Immunoglobulin Produced by an Established Cell Line of Human Myeloma Cell Origin: II. Identity of λ-chains in cells and in medium
NO832905L (no) Carcinoembryonalt antigen, fremgangsmaate til dets isolering og dets anvendelse
CA1165685A (en) Purified prostatic tissue antigen
Laurell et al. The relation between the proteins of plasma and milk in the rat
JPH076982B2 (ja) 抗 体
Sato et al. Acidic glycoproteins from bovine compact bone
Fahey et al. Separation of 6.6 S and 18S gamma globulins with isohemagglutinin activity
Dreesman et al. Properties of Papain-Digested Chicken 7 S γ-Globulin
O'Donnell et al. Microvillar iron-binding glycoproteins isolated from the rabbit small intestine
US4524027A (en) Membrane-associated proteins (MP2), a process for obtaining them, and their use
Syversen et al. Rapid, high-yield isolation of human chromogranin A from chromaffin granules of pheochromocytomas
Benveniste et al. Heterogeneity of Purified Human Pituitary Luteinizing Hormone: Effect on HormoneMeasurement by Radioimmunoassay
Mouriz et al. Purification of human 19S thyroglobulin by gel filtration
Laskov et al. Studies on a naturally occurring human antibody active against mouse Landschutz ascites tumor cells: II. Identification of the antibody as IgM and its partial purification